Breast cancer treatment advances with light-activated 'smart bomb'
Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...
clinicaladvisor.com21h
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.
Cure Today21h
FDA Approval of Calquence Combo Brings Optimism in MCL
Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...
PipelineReview.com4h
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
(NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Application (BLA) for linvoseltamab for the treatment ...